VERTEX PHARMACEUTICA

VRTX

Delayed - 06/28 04:00:01 pm
276.17USD	-3.88%

Turn to zoom

Prev.	276.1700
Open	288.4500
High	289.4100
Low	275.9700
Volume	1 926 506

13h ago	Insider Sell: Vertex Pharmaceuticals
06/15	Transcript : Vertex Pharmaceuticals Incorporated Presents at Goldman Sachs...
06/13	Cowen Adjusts Price Target on Vertex Pharmaceuticals to $310 From $305,...
06/13	Argus Adjusts Price Target on Vertex Pharmaceuticals to $280 From $275,...

	Short Term	Mid-Term	Long Term
Trend	Bullish	Bullish	Bullish
Resistance	293	293	293
Spread/Res.	-5,6%	-5,6%	-5,6%
Spread/Supp.	2,8%	10%	20%
Support	269	251	230

Sales 2022	8 593 M - -
Net income 2022	3 246 M - -
Net cash 2022	10 813 M - -
P/E ratio 2022	21,9x
Yield 2022	-

Capitalization	70 632 M 70 632 M -
EV / Sales 2022	6,96x
EV / Sales 2023	6,04x
Nbr of Employees	3 900
Free-Float	99,7%

Vertex Pharmaceuticals Incorporated specializes in the research, development and marketing of micromolecular drugs primarily for the treatment of cancers, viral, inflammatory and auto-immune diseases. Net sales break down by type of income as follows:
- income from sales of products (99.9%);
-...

Sector :

Bio Therapeutic Drugs

Calendar :

2022-07-27 Earnings Release

Trading Rating :

Investor Rating :

Sell Buy
Mean consensus	OUTPERFORM
Number of Analysts	26
Last Close Price	276,17 $
Average target price	294,22 $
Spread / Average Target	6,53%